| 2025-12-29 | +90.8% | expansion | Seeking Alpha | Applied Digital to spin out cloud business, to combine with EKSO to launch Chronoscale |
| 2025-12-29 | +90.8% | legal | SEC EDGAR | EKSO 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-12-29 | +90.8% | news | TradingView | Ekso Bionics Holdings, Inc. Announces Proposed Business Combination with Applied Digital - TradingView |
| 2025-12-30 | +59.1% | news | TipRanks | Why Ekso Bionics (EKSO) Stock Is Soaring Today - TipRanks |
| 2025-12-30 | +59.1% | news | StocksToTrade | EKSO Stock Soars: An Unexpected Surge - StocksToTrade |
| 2025-12-30 | +59.1% | news | Benzinga | Why Is Ekso Bionics Stock Soaring Tuesday? - Applied Digital (NASDAQ:APLD), Ekso Bionics Holdings (NASDAQ - Benzinga |
| 2025-12-30 | +59.1% | M&A | The AI Journal | EKSO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of EKSO Bionics Holdings, Inc. Is Fair to Shareholders - The AI Journal |
| 2025-12-30 | +59.1% | news | Finviz | Applied Digital Stock Moves Higher on Spin-Off Buzz - Finviz |
| 2025-12-30 | +59.1% | news | The Business Journals | Applied Digital to spin out cloud computing business, combine it with exoskeleton company - The Business Journals |
| 2024-01-16 | +32.7% | legal | SEC EDGAR | EKSO 8-K: 8.01 and (SEC Filing) |
| 2025-07-28 | -31.5% | earnings | Seeking Alpha | Ekso Bionics outlines AI-powered rehabilitation push as personal health revenues grow 50% amid temporary enterprise sales delays |
| 2025-07-28 | -31.5% | earnings | Seeking Alpha | Ekso Bionics Holdings, Inc. (EKSO) Q2 2025 Earnings Call Transcript |
| 2025-07-28 | -31.5% | earnings | Seeking Alpha | Ekso Bionics Holdings GAAP EPS of -$1.24 beats by $0.11, revenue of $2.06M misses by $2.25M |
| 2025-07-28 | -31.5% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2026-02-17 | +30.5% | legal | MT Newswires | Ekso Bionics Holdings Insider Bought Shares Worth $970,069, According to a Recent SEC Filing |
| 2026-02-17 | +30.5% | analyst | Zacks | Is Compass Therapeutics, Inc. (CMPX) Outperforming Other Medical Stocks This Year? |
| 2026-02-17 | +30.5% | legal | SEC EDGAR | EKSO 8-K: 1.01, 2.02, 3.02, 3.03, 5.01, 5.02, 5.03 (SEC Filing) |
| 2026-02-17 | +30.5% | news | TradingView | Ekso Bionics to Combine With Applied Digital Cloud; Issuing 138.2M Shares, Rebrands ChronoScale - TradingView |
| 2024-07-30 | -30.4% | earnings | Seeking Alpha | Ekso Bionics Holdings, Inc. (EKSO) Q2 2024 Earnings Call Transcript |
| 2024-03-05 | -28.1% | earnings | Seeking Alpha | Ekso Bionics Holdings, Inc. (EKSO) Q4 2023 Earnings Call Transcript |
| 2025-06-18 | -25.6% | news | Seeking Alpha | Ekso Bionics showcases AI integration breakthrough in exoskeleton devices |
| 2025-12-31 | -25.3% | analyst | GuruFocus | EKSO Stock Downgraded to Neutral by HC Wainwright & Co. | EKSO S - GuruFocus |
| 2025-12-31 | -25.3% | news | Barchart | Applied Digital Just Sent Little-Known Ekso Bionics Stock Soaring. Should You Buy Shares Here? - Barchart |
| 2025-12-31 | -25.3% | M&A | StocksToTrade | EKSO Bionics Faces Regulatory Scrutiny Over Merger Actions - StocksToTrade |
| 2025-12-31 | -25.3% | M&A | timothysykes.com | EKSO Bionics Faces Investigation Amidst Merger with Applied Digital Cloud - timothysykes.com |
| 2024-01-11 | -22.5% | news | Seeking Alpha | Ekso Bionics announces $4.6M registered direct offering |
| 2025-05-19 | -22.0% | news | Seeking Alpha | Ekso Bionics announces 1-for-15 reverse stock split |
| 2025-05-19 | -22.0% | news | Finimize | Tech Giants Tumble: Surprising Share Swings Shake Market - Finimize |
| 2025-05-20 | -21.9% | legal | SEC EDGAR | EKSO 8-K: 5.07, 8.01 (SEC Filing) |
| 2026-01-05 | +20.3% | legal | PR Newswire | $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO) - PR Newswire |
| 2024-03-04 | -19.5% | earnings | Seeking Alpha | Ekso Bionics Holdings GAAP EPS of -$0.22 misses by $0.11, revenue of $4.84M beats by $0.07M |
| 2024-03-04 | -19.5% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2026-04-10 | +19.2% | news | Stock Titan | Executive pay, ownership and board structure detailed in Ekso Bionics (NASDAQ: EKSO) 2025 10-K/A - Stock Titan |
| 2024-07-29 | -18.0% | news | Seeking Alpha | Ekso Bionics files to sell common stock, warrants |
| 2024-07-29 | -18.0% | earnings | Seeking Alpha | Ekso Bionics Holdings GAAP EPS of -$0.13 in-line, revenue of $4.95M misses by $0.22M |
| 2024-07-29 | -18.0% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2025-04-25 | +17.4% | news | Stock Titan | Ekso Bionics Stock Price, News & Analysis - Stock Titan |
| 2022-10-31 | +14.9% | legal | SEC EDGAR | EKSO 8-K: 5.02 (SEC Filing) |
| 2024-07-28 | +14.2% | earnings | Seeking Alpha | Ekso Bionics Holdings Q2 Earnings Preview |
| 2024-07-27 | +14.2% | news | InvestorPlace | The 3 Best Robotic Exoskeleton Stocks to Buy Now - InvestorPlace |
| 2026-02-20 | -13.2% | news | AD HOC NEWS | Ekso Bionics Stock: Tiny Exoskeleton Player With Big-Cap Risks - AD HOC NEWS |
| 2025-01-13 | -12.3% | legal | SEC EDGAR | EKSO 8-K: 2.02, 8.01 (SEC Filing) |
| 2022-12-05 | +12.2% | legal | SEC EDGAR | EKSO 8-K: 2.01, 5.02, 7.01 (SEC Filing) |
| 2026-01-22 | +10.4% | legal | SEC EDGAR | EKSO 8-K: 1.01, 3.02, 5.03 (SEC Filing) |
| 2022-11-03 | -10.2% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2023-04-26 | -9.3% | legal | SEC EDGAR | EKSO 8-K: 5.02, 5.03 (SEC Filing) |
| 2025-03-04 | -9.0% | earnings | Seeking Alpha | Ekso Bionics Holdings, Inc. (EKSO) Q4 2024 Earnings Call Transcript |
| 2025-05-05 | -8.9% | earnings | Seeking Alpha | Ekso bionics anticipates scaling personal health revenues in 2025 with new partnerships |
| 2025-05-05 | -8.9% | earnings | Seeking Alpha | Ekso Bionics Holdings, Inc. (EKSO) Q1 2025 Earnings Call Transcript |
| 2025-05-05 | -8.9% | earnings | Seeking Alpha | Ekso Bionics Holdings GAAP EPS of -$0.12 misses by $0.01, revenue of $3.38M misses by $1.24M |
| 2025-05-05 | -8.9% | earnings | Seeking Alpha | Ekso Bionics Holdings Q1 Earnings Preview |
| 2025-05-05 | -8.9% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2024-10-28 | -8.2% | earnings | Seeking Alpha | Ekso Bionics Holdings, Inc. (EKSO) Q3 2024 Earnings Call Transcript |
| 2024-10-28 | -8.2% | earnings | Seeking Alpha | Ekso Bionics Holdings GAAP EPS of -$0.10 in-line, revenue of $4.13M misses by $1.42M |
| 2024-10-28 | -8.2% | earnings | Seeking Alpha | Ekso Bionics Holdings Q3 Earnings Preview |
| 2024-10-28 | -8.2% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2026-02-01 | +7.2% | news | AD HOC NEWS | Ekso Bionics stock wobbles near lows as investors weigh dilution risk against robotic rehab promise - AD HOC NEWS |
| 2025-09-17 | +7.2% | legal | SEC EDGAR | EKSO 8-K: 1.01, 1.02, 2.03 (SEC Filing) |
| 2025-10-29 | +7.1% | news | GlobeNewswire | Ekso Bionics Announces $3.7 Million Registered Direct - GlobeNewswire |
| 2021-11-02 | +7.1% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2023-08-18 | -7.0% | legal | SEC EDGAR | EKSO 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-01-27 | +6.9% | analyst | Simply Wall St. | How The New Price Target Is Shaping Ekso Bionics Holdings (EKSO) Story |
| 2026-01-27 | +6.9% | analyst | Yahoo Finance | How The New Price Target Is Shaping Ekso Bionics Holdings (EKSO) Story - Yahoo Finance |
| 2025-03-03 | -6.4% | earnings | Seeking Alpha | Ekso Bionics Holdings GAAP EPS of -$0.14 misses by $0.06, revenue of $5.09M beats by $0.04M |
| 2025-03-03 | -6.4% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2025-10-28 | +6.4% | earnings | Seeking Alpha | Ekso Bionics Holdings GAAP EPS of -$0.54 beats by $0.42, revenue of $4.23M beats by $0.07M |
| 2025-10-28 | +6.4% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2025-07-30 | +6.3% | earnings | Yahoo Finance | Ekso Bionics Holdings Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance |
| 2026-02-26 | +6.2% | earnings | Zacks | Integra LifeSciences (IART) Beats Q4 Earnings and Revenue Estimates |
| 2022-04-28 | -6.1% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2023-07-27 | -5.9% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2026-04-11 | +5.8% | news | Minichart | Ekso Bionics Holdings 2025 10-K/A: Executive Compensation, Board Governance, and Major Financial Disclosures - Minichart |
| 2023-03-28 | -5.8% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2024-03-03 | +5.6% | earnings | Seeking Alpha | Ekso Bionics Holdings Q4 Earnings Preview |
| 2024-03-03 | +5.6% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2026-01-21 | -5.5% | news | Seeking Alpha | Ekso Bionics prices $5.9M private placement |
| 2026-01-21 | -5.5% | news | Stock Titan | Exoskeleton firm Ekso Bionics lines up $5.9M in new funding - Stock Titan |
| 2026-01-21 | -5.5% | news | The Manila Times | Ekso Bionics Prices $5.852 million Private Placement - The Manila Times |
| 2025-04-10 | -5.4% | news | Seeking Alpha | Ekso Bionics files to sell 10.5M shares of common stock for holders |
| 2022-01-21 | -5.3% | legal | SEC EDGAR | EKSO 8-K: 5.02, 8.01 (SEC Filing) |
| 2026-02-11 | -4.9% | earnings | Simply Wall St. | How The Ekso Bionics Holdings Narrative Is Shifting After Q3 And A Higher Price Target |
| 2026-02-11 | -4.9% | earnings | Yahoo Finance | How The Ekso Bionics Holdings Narrative Is Shifting After Q3 And A Higher Price Target - Yahoo Finance |
| 2026-02-02 | +4.6% | earnings | Yahoo Finance | Beat the Market the Zacks Way: Five Below, Novo Nordisk, Ekso in Focus - Yahoo Finance |
| 2026-02-02 | +4.6% | news | Seeking Alpha | Cheap high flyer healthcare stocks - high momentum and low valuation (CLYM:NASDAQ) - Seeking Alpha |
| 2025-11-01 | -4.5% | news | The Press Democrat | Marin County medical exoskeleton maker considers new direction - The Press Democrat |
| 2021-12-28 | -3.9% | legal | SEC EDGAR | EKSO 8-K: 5.02 (SEC Filing) |
| 2026-04-23 | -3.8% | earnings | UBND thành phố Hải Phòng | EKSO (Ekso Bionics Holdings Inc.) reports far wider Q4 2025 loss than analyst estimates, as shares rise despite steep quarterly earnings underperformance. - Elite Trading Signals - UBND thành phố Hải Phòng |
| 2024-08-30 | +3.8% | news | Seeking Alpha | Ekso Bionics prices $6M offering |
| 2022-01-10 | -3.8% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2026-01-12 | +3.7% | news | Yahoo Finance | How Recent Developments Are Rewriting The Story For Ekso Bionics Holdings (EKSO) - Yahoo Finance |
| 2023-07-28 | -3.7% | legal | SEC EDGAR | EKSO 8-K: 8.01 and (SEC Filing) |
| 2023-04-27 | +3.6% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2025-10-30 | +3.4% | legal | SEC EDGAR | EKSO 8-K: 3.02, 8.01 (SEC Filing) |
| 2025-12-04 | -3.2% | news | timothysykes.com | Ekso Bionics Faces Market Challenges Amid Financial Struggles - timothysykes.com |
| 2025-12-04 | -3.2% | news | Stock Titan | Ekso Bionics (Nasdaq: EKSO) to Distribute MediTouch BalanceTutor Rehab System in U.S. - Stock Titan |
| 2025-12-23 | +3.0% | news | simplywall.st | Ekso Bionics Holdings, Inc.'s (NASDAQ:EKSO) Shares Bounce 29% But Its Business Still Trails The Industry - simplywall.st |
| 2024-09-03 | -2.9% | legal | SEC EDGAR | EKSO 8-K: 1.01 and (SEC Filing) |
| 2022-02-24 | +2.9% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2026-04-09 | +2.8% | news | Stock Titan | Mink Brook entities report 190,596 shares in Ekso Bionics (NASDAQ: EKSO) - Stock Titan |
| 2022-12-09 | -2.7% | legal | SEC EDGAR | EKSO 8-K: 5.02 (SEC Filing) |
| 2026-03-20 | +2.6% | executive | Investing.com | Ekso Bionics (EKSO) COO Jones buys $15,499 in company stock - Investing.com |
| 2026-03-20 | +2.6% | executive | Stock Titan | Ekso Bionics (EKSO) COO adds 1,308 shares through 401(k) matching purchase - Stock Titan |
| 2026-03-20 | +2.6% | executive | Stock Titan | Ekso Bionics (EKSO) CFO adds 1,308 common shares through 401(k) plan - Stock Titan |
| 2026-03-20 | +2.6% | M&A | Investing.com | Ekso Bionics CFO Wong acquires $15,499 in shares - Investing.com |
| 2025-05-31 | +2.5% | news | Intellectia AI | EKSO Forecast — Price Prediction for 2026. Should I Buy EKSO? - Intellectia AI |
| 2025-05-21 | -2.5% | legal | SEC EDGAR | EKSO 8-K: 8.01 and (SEC Filing) |
| 2024-01-05 | +2.4% | legal | SEC EDGAR | EKSO 8-K: 2.02, 8.01 (SEC Filing) |
| 2021-04-29 | +2.2% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2026-01-02 | -1.9% | M&A | Investing.com | H.C. Wainwright downgrades Ekso Bionics stock rating to Neutral amid merger - Investing.com |
| 2026-01-28 | +1.8% | news | GlobeNewswire | Construction Exoskeleton Market Trends and Supply Chain Analysis 2026-2030 & 2035 - AI-Driven Exosuits Transforming the Construction Landscape |
| 2025-03-17 | +1.7% | legal | SEC EDGAR | EKSO 8-K: 1.01, 3.02, 3.03 (SEC Filing) |
| 2023-09-29 | -1.7% | legal | SEC EDGAR | EKSO 8-K: 1.01 and 3.01 (SEC Filing) |
| 2023-10-26 | +1.5% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2025-11-07 | +1.4% | legal | SEC EDGAR | EKSO 8-K: 5.02 and (SEC Filing) |
| 2022-05-26 | -1.1% | legal | SEC EDGAR | EKSO 8-K: 5.02 and (SEC Filing) |
| 2022-03-10 | +1.0% | legal | SEC EDGAR | EKSO 8-K: 5.02 and (SEC Filing) |
| 2026-03-29 | -0.8% | news | Simply Wall St. | Applied Digital Reshapes AI Cloud And Debt Profile With ChronoScale Move |
| 2023-06-12 | -0.8% | legal | SEC EDGAR | EKSO 8-K: 1.01, 5.07 (SEC Filing) |
| 2023-11-14 | +0.8% | legal | SEC EDGAR | EKSO 8-K: 8.01 (SEC Filing) |
| 2024-01-04 | +0.6% | earnings | Seeking Alpha | Ekso Bionics expects Q4 revenue in the range of $4.7M to $4.9M |
| 2024-04-29 | +0.4% | earnings | Seeking Alpha | Ekso Bionics Holdings, Inc. (EKSO) Q1 2024 Earnings Call Transcript |
| 2024-04-29 | +0.4% | earnings | Seeking Alpha | Ekso Bionics Holdings GAAP EPS of -$0.20 misses by $0.04, revenue of $3.8M misses by $1.19M |
| 2024-04-29 | +0.4% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2022-07-28 | +0.2% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2021-07-29 | -0.1% | legal | SEC EDGAR | EKSO 8-K: 2.02 and (SEC Filing) |
| 2026-04-26 | — | news | TradingView | EBITDA per share of Ekso Bionics Holdings, Inc. – MUN:23E0 - TradingView |